Type 2 Diabetes and Weight Loss following Biliopancreatic Diversion for Obesity

被引:0
|
作者
Giuseppe M Marinari
Francesco S Papadia
Lucia Briatore
Gianfranco Adami
Nicola Scopinaro
机构
来源
Obesity Surgery | 2006年 / 16卷
关键词
MORBID OBESITY; BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION; TYPE 2 DIABETES; WEIGHT LOSS;
D O I
暂无
中图分类号
学科分类号
摘要
Background: The authors investigated the weight loss and maintenance in type 2 diabetic obese patients undergoing biliopancreatic diversion (BPD). Methods: Two series of diabetic and non-diabetic obese patients matched for gender, age and baseline body mass index (BMI) were evaluated prior to BPD, on the occasion of the regular follow-up visit at 1, 2 and 3 years following the operation, and at the fifth postoperative year. At each follow-up point, body weight (BW), BMI, and serum glucose concentration were measured. Results: In all type 2 diabetic patients, the serum glucose level fell to within the normal range at the first postoperative year and remained within normal limits without any medication throughout all the follow-up period. In preoperatively diabetic subjects, mean values of BW and BMI were closely similar to those of non-diabetic subjects at all follow-up points, and the stabilization weight was independently related to age and to initial BW values. Conclusions: In obese patients with type 2 diabetes, the glucose level steadily normalized in every case following BPD, and values remained unchanged throughout the follow-up period. After the operation, the type 2 diabetic obese patients experienced the same stable weight reduction as their non-diabetic counterparts.
引用
收藏
页码:1440 / 1444
页数:4
相关论文
共 50 条
  • [41] Effects of Weight Loss after Biliopancreatic Diversion on Metabolism and Cardiovascular Profile
    Rosa Palomar
    Gema Fernández-Fresnedo
    Agustín Domínguez-Diez
    Maite López-Deogracias
    Francisco Olmedo
    Angel L Martín de Francisco
    Saturnino Sanz de Castro
    Fernando Casado Martín
    Manuel Gómez-Fleitas
    Manuel Arias
    Carlos Fernández-Escalante
    Obesity Surgery, 2005, 15 : 794 - 798
  • [42] Biliopancreatic diversion for the treatment of morbid obesity
    Larrad-Jimenez, Alvaro
    OBESITY AND METABOLISM-MILAN, 2008, 4 (01): : 12 - 21
  • [43] HEALTH STATE UTILITIES ASSOCIATED WITH WEIGHT LOSS IN TYPE 2 DIABETES AND OBESITY
    Boye, K.
    Matza, L.
    Stewart, K.
    Andrews, H.
    Howell, T. A.
    Stefanski, A.
    Malley, K. G.
    Ishak, K. J.
    Lando, Fernandez L.
    VALUE IN HEALTH, 2022, 25 (01) : S230 - S230
  • [44] Health state utilities associated with weight loss in type 2 diabetes and obesity
    Boye, Kristina S.
    Matza, Louis S.
    Stewart, Katie D.
    Andrews, Haylee
    Howell, Timothy A.
    Stefanski, Adam
    Malley, Karen G.
    Ishak, K. Jack
    Lando, Laura Fernandez
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 14 - 25
  • [45] Analysis of Weight Loss with the Biliopancreatic Diversion of Larrad: Absolute Failures or Relative Successes?
    Carlos Sánchez-Cabezudo Diaz-Guerra
    Alvaro Larrad Jiménez
    Obesity Surgery, 2002, 12 : 249 - 252
  • [46] Analysis of weight loss with the biliopancreatic diversion of Larrad:: Absolute failures or relative successes?
    Diaz-Guerra, CSC
    Jiménez, AL
    OBESITY SURGERY, 2002, 12 (02) : 249 - 252
  • [48] Serum leptin and weight loss in severely obese patients undergoing biliopancreatic diversion
    GF Adami
    R Cordera
    A Campostano
    A Bressani
    F Cella
    N Scopinaro
    International Journal of Obesity, 1998, 22 : 822 - 824
  • [49] Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity
    G F Adami
    R Cordera
    G Camerini
    G M Marinari
    N Scopinaro
    International Journal of Obesity, 2004, 28 : 671 - 673
  • [50] Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity
    Adami, GF
    Cordera, R
    Camerini, G
    Marinari, GM
    Scopinaro, N
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (05) : 671 - 673